AlloVir, Inc. (ALVR)
Mar 18, 2025 - ALVR was delisted (reason merged into KLRS)
9.81
+0.39 (4.14%)
Inactive · Last trade price
on Mar 18, 2025
AlloVir Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
49.21M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionALVR News
- 5 weeks ago - Kalaris Announces Closing of Merger with AlloVir - GlobeNewsWire
- 6 weeks ago - Kalaris and AlloVir Announce Stockholder Approval of Merger - GlobeNewsWire
- 2 months ago - ALLOVIR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AlloVir, Inc. - ALVR - Business Wire
- 5 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMKR and ALVR on Behalf of Shareholders - GlobeNewsWire
- 5 months ago - AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina - GlobeNewsWire
- 7 months ago - Kuehn Law Encourages Investors of AlloVir, Inc. to Contact Law Firm - GlobeNewsWire
- 1 year ago - FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
- 1 year ago - FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire